Abstract
Obstructive sleep apnea syndrome (OSAS) is a well-known independent risk factor for developing cardiovascular/cerebrovascular diseases. However, the underlying pathomechanisms of how recurrent respiratory events impair cerebral perfusion are still unknown. In this controlled study we quantify how different pathophysiological mechanisms contribute to changes in cerebral perfusion and oxygenation during sleep apneas/hypopneas before and during continuous positive airway pressure (CPAP) treatment. OSAS patients underwent a stepwise incremental CPAP titration protocol during polysomnography recordings: 1-h sleep without CPAP served as self-controlled baseline followed by stepwise increments of 1-cmH2O pressure per-hour starting from 5-8 cmH2O individually. Frequency-domain near-infrared spectroscopy measured blood volume (BV) and oxygen saturation (StO2) in the left forehead. The coefficients of variation of BV (CV-BV) and the decreases of StO2 (de-StO2) during respiratory events were predicted by age, sex, body-mass-index, sleep stages, sleep positions, types and durations of events, mean heart rate (HR) during events, CPAP pressures and the apnea-hypopnea-index/arousal-index/leg-movement-index under different CPAP pressures using linear mixed-effect models, respectively. Longer events and apneas rather than hypopneas induce larger CV-BV and stronger cerebral desaturations. Events with higher cerebral StO2 preceding onsets, occurring during rapid-eye-movement sleep and associated with higher HR cause smaller CV-BV and de-StO2. Sleep position influences the changes in cerebral BV. CPAP pressures stepwise attenuate the changes in CV-BV and de-StO2. The length of respiratory event may indicate the severity of cerebral vascular damage in OSAS. Brain activity (e.g., sleep stages and baseline StO2) and systemic HR/CPAP pressures also affect the changes in cerebral perfusion and desaturation in OSAS.
Key Message The underlying pathomechanisms of how recurrent respiratory events in OSAS impair cerebral perfusion are still unknown. We found that in OSAS-patients the length and the type but not the number of the respiratory events (as indexed by AHI) are the strongest predictor of changes in brain perfusion/oxygenation and CPAP therapy can attenuate the induced brain hemodynamic changes. Our study provides evidence based on cerebral hemodynamic changes to support the notion that the duration of the apnea/hypopnea events rather than AHI may better indicate the severity of OSAS.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by Clinic Barmelweid Scientific Foundation. The data acquisition work was supported by the Research Fund of the Swiss Lung Association No.2014/22.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study was approved by the local ethical commission of Northwest Switzerland, and was in compliance with the declaration of Helsinki.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The data are available from the authors on a reasonable request.
